市場調査レポート

商品コード

1239542

外傷性脳損傷（TBI）評価市場：エンドユーザー別、診断タイプ別（CT-スキャン、MRI、頭蓋内圧モニタリング、脳組織酸素分圧、その他）：世界の機会分析と産業予測、2021年～2031年

Traumatic brain injuries assessment Market By End-user, By Diagnostic Type (CT-Scan, MRI, Intracranial Pressure Monitoring, Partial Pressure of Oxygen in Brain Tissue, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

出版日: 2023年01月01日 | 発行: Allied Market Research

| ページ情報: 英文 250 Pages | 納期: 2～3営業日

価格

Cloud Access (Single User License)

USD 3,570 560,989円

レポートのクラウドアクセスでご利用頂けるライセンスです。ウェブポータルで配信され、60日間レポートにアクセスできます。この期間を過ぎるとレポートへのアクセスは失効します。コンテンツのダウンロード、印刷、共有、コピー＆ペーストはできません。

PDF (Business License)

USD 5,730 900,412円

レポートPDFをご利用いただけるライセンスです。ライセンスを付与されたPCでのみレポートPDFの保存、表示、利用が可能です。PDFl内のテキスト等のコピー＆ペーストは可能です。印刷は5回可能です。追加料金を支払うことで、2～5ユーザーを収容できるようにアップグレードできます。

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

USD 9,600 1,508,544円

レポートPDFとExcel定量データをひとつの企業、及びその子会社でご利用頂けるライセンスです。ライセンスを付与されたPCでのみレポートPDFとExcelの保存、表示、利用が可能です。PDFとExcel内のテキスト等のコピー＆ペーストは可能です。PDFとExcelの印刷回数の制限はありません。印刷したレポートの利用は企業、及びその子会社内にて共有可能です。無料でレポートのアップデートがご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.14円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

外傷性脳損傷（TBI）評価の世界市場規模は2021年に95億7,000万米ドルで、2031年には183億7,360万米ドルの収益を生み出し、CAGR 7.0%で拡大すると予測されます。

外傷性脳損傷（TBI）評価市場の成長は、インドにおける重要な公衆衛生問題です。外傷性脳損傷は、若く活発な社会人の死亡、危害、障害に寄与しています。インドでは、TBIによる莫大な経済的損失が発生していますが、数値化することはできません。インドでは、自動車の普及と都市化の進展に伴い、TBIが増加することが予想されます。世界保健機関（WHO）が最近発表した「交通事故による傷害の予防と暴力と健康」に関する世界報告書は、傷害の問題が世界中でいかに深刻になっているか、予防、管理、リハビリテーションのプログラムを緊急に設計し評価する必要があるかを明らかにしています。インドは、予防を優先していない国のひとつです。

TBIは、実行機能と自制心に悪影響を及ぼします。ストレスや不安に関連する行動をコントロールする能力は、自己調整と呼ばれています。TBIを受けた人の場合、落ち着くのが難しい、順番を待つのが難しい、見知らぬ環境で感情が高ぶるといったことが起こりえます。実行機能とは、計画、記憶、目標設定、注意集中、指示に従うことに関わる高次の脳機能を指します。TBIの患者さんは、混乱しやすく、物事を忘れやすいため、新しい情報を学んだり、書類を作成したり、公共交通機関を利用したりすることが困難になる場合があります。

市場参入企業による最新技術の採用や新製品の発売は、予測期間中の市場拡大を加速させると予想されます。例えば、Bio Direction, Inc.のNanoDxシステムは、脳震盪/TBIを2分以内に正確に診断する迅速なポイントオブケア（POC）診断薬です。

国立障害・自立生活・リハビリテーション研究所（NIDILRR）の助成を受けているこの研究はまだ進行中ですが、予備的な調査結果では、パンデミックは、社会的孤立、日常生活の混乱、認知への影響など、脳損傷を受けた人に大きな影響を与えることが分かっています。地域生活支援局が資金を提供する外傷性脳損傷技術支援・資料センター（TBI TARC）は、COVID-19が脳損傷者にどのような影響を与えたかをさらに調査することに着手しました。TBIアドバイザリー・リーダーシップ（TAL）グループの5人のメンバーは、TBI TARCから質問されました。TALグループの目的は、TBI TARCの優先順位を指示することです。

市場の定義と範囲
主な調査結果
- 主な投資ポケット
ポーターのファイブフォース分析
市場力学
- 促進要因
- 抑制要因
- 機会
市場におけるCOVID-19影響分析
バリューチェーン分析
主な規制分析
特許情勢
規制ガイドライン
市場シェア分析

第4章外傷性脳損傷（TBI）評価市場：エンドユーザー別

概要
- 市場規模と予測
病院
- 主要な市場動向、成長要因と機会
- 市場規模と予測：地域別
- 市場シェア分析：国別
診断センター
- 主要な市場動向、成長要因と機会
- 市場規模と予測：地域別
- 市場シェア分析：国別
その他
- 主要な市場動向、成長要因と機会
- 市場規模と予測：地域別
- 市場シェア分析：国別

第5章外傷性脳損傷（TBI）評価市場：診断タイプ別

概要
- 市場規模と予測
CTスキャン
- 主要な市場動向、成長要因と機会
- 市場規模と予測：地域別
- 市場シェア分析：国別
MRI
- 主要な市場動向、成長要因と機会
- 市場規模と予測：地域別
- 市場シェア分析：国別
頭蓋内圧モニタリング
- 主要な市場動向、成長要因と機会
- 市場規模と予測：地域別
- 市場シェア分析：国別
脳組織酸素分圧（pBrO2）
- 主要な市場動向、成長要因と機会
- 市場規模と予測：地域別
- 市場シェア分析：国別
その他
- 主要な市場動向、成長要因と機会
- 市場規模と予測：地域別
- 市場シェア分析：国別

第6章外傷性脳損傷（TBI）評価市場：地域別

概要
- 市場規模と予測
北米
- 主な動向と機会
- 北米の市場規模と予測：エンドユーザー別
- 北米の市場規模と予測：診断タイプ別
- 北米市場規模と予測：国別
  - 米国
  - 主要な市場動向、成長要因と機会
  - 市場規模と予測：エンドユーザー別
  - 市場規模と予測：診断タイプ別
  - カナダ
  - 主要な市場動向、成長要因と機会
  - 市場規模と予測：エンドユーザー別
  - 市場規模と予測：診断タイプ別
  - メキシコ
  - 主要な市場動向、成長要因と機会
  - 市場規模と予測：エンドユーザー別
  - 市場規模と予測：診断タイプ別
欧州
- 主な動向と機会
- 欧州の市場規模と予測：エンドユーザー別
- 欧州の市場規模と予測：診断タイプ別
- 欧州の市場規模と予測：国別
  - ドイツ
  - 主要な市場動向、成長要因と機会
  - 市場規模と予測：エンドユーザー別
  - 市場規模と予測：診断タイプ別
  - 英国
  - 主要な市場動向、成長要因と機会
  - 市場規模と予測：エンドユーザー別
  - 市場規模と予測：診断タイプ別
  - フランス
  - 主要な市場動向、成長要因と機会
  - 市場規模と予測：エンドユーザー別
  - 市場規模と予測：診断タイプ別
  - スペイン
  - 主要な市場動向、成長要因と機会
  - 市場規模と予測：エンドユーザー別
  - 市場規模と予測：診断タイプ別
  - イタリア
  - 主要な市場動向、成長要因と機会
  - 市場規模と予測：エンドユーザー別
  - 市場規模と予測：診断タイプ別
  - その他欧州
  - 主要な市場動向、成長要因と機会
  - 市場規模と予測：エンドユーザー別
  - 市場規模と予測：診断タイプ別
アジア太平洋
- 主な動向と機会
- アジア太平洋の市場規模と予測：エンドユーザー別
- アジア太平洋市場の規模と予測：診断タイプ別
- アジア太平洋の市場規模と予測：国別
  - 中国
  - 主要な市場動向、成長要因と機会
  - 市場規模と予測：エンドユーザー別
  - 市場規模と予測：診断タイプ別
  - 日本
  - 主要な市場動向、成長要因と機会
  - 市場規模と予測：エンドユーザー別
  - 市場規模と予測：診断タイプ別
  - インド
  - 主要な市場動向、成長要因と機会
  - 市場規模と予測：エンドユーザー別
  - 市場規模と予測：診断タイプ別
  - 韓国
  - 主要な市場動向、成長要因と機会
  - 市場規模と予測：エンドユーザー別
  - 市場規模と予測：診断タイプ別
  - オーストラリア
  - 主要な市場動向、成長要因と機会
  - 市場規模と予測：エンドユーザー別
  - 市場規模と予測：診断タイプ別
  - その他アジア太平洋地域
  - 主要な市場動向、成長要因と機会
  - 市場規模と予測：エンドユーザー別
  - 市場規模と予測：診断タイプ別
ラテンアメリカ・中東・アフリカ
- 主な動向と機会
- LAMEAの市場規模と予測：エンドユーザー別
- LAMEAの市場規模と予測：診断タイプ別
- LAMEAの市場規模と予測：国別
  - ブラジル
  - 主要な市場動向、成長要因と機会
  - 市場規模と予測：エンドユーザー別
  - 市場規模と予測：診断タイプ別
  - サウジアラビア
  - 主要な市場動向、成長要因と機会
  - 市場規模と予測：エンドユーザー別
  - 市場規模と予測：診断タイプ別
  - アラブ首長国連邦
  - 主要な市場動向、成長要因と機会
  - 市場規模と予測：エンドユーザー別
  - 市場規模と予測：診断タイプ別
  - 南アフリカ
  - 主要な市場動向、成長要因と機会
  - 市場規模と予測：エンドユーザー別
  - 市場規模と予測：診断タイプ別
  - その他のラテンアメリカ・中東・アフリカ
  - 主要な市場動向、成長要因と機会
  - 市場規模と予測：エンドユーザー別
  - 市場規模と予測：診断タイプ別

第7章競合情勢

イントロダクション
主要成功戦略
トップ 10プレーヤーの製品マッピング
競合ダッシュボード
競合ヒートマップ
トッププレーヤーのポジショニング、2021

第8章企業プロファイル

brainscope company inc.
NOVASIGNAL CORPORATION
Integra LifeSciences Holdings Corporation
Natus Medical Incorporated
Boston Scientific Corporation
Koninklijke Philips N.V.
BioDirection, Inc.
Nihon Kohden Corp.
RAUMEDIC AG
Compumedics Ltd.

図表

LIST OF TABLES

TABLE 1. GLOBAL TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
TABLE 2. TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET FOR HOSPITAL, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 3. TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET FOR DIAGNOSTICS CENTER, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 4. TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 5. GLOBAL TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY DIAGNOSTIC TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 6. TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET FOR CT-SCAN, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 7. TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET FOR MRI, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 8. TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET FOR INTRACRANIAL PRESSURE MONITORING, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 9. TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET FOR PARTIAL PRESSURE OF OXYGEN IN BRAIN TISSUE (PBRO2), BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 10. TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 11. TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 12. NORTH AMERICA TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
TABLE 13. NORTH AMERICA TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY DIAGNOSTIC TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 14. NORTH AMERICA TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 15. U.S. TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
TABLE 16. U.S. TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY DIAGNOSTIC TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 17. CANADA TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
TABLE 18. CANADA TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY DIAGNOSTIC TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 19. MEXICO TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
TABLE 20. MEXICO TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY DIAGNOSTIC TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 21. EUROPE TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
TABLE 22. EUROPE TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY DIAGNOSTIC TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 23. EUROPE TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 24. GERMANY TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
TABLE 25. GERMANY TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY DIAGNOSTIC TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 26. UK TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
TABLE 27. UK TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY DIAGNOSTIC TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 28. FRANCE TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
TABLE 29. FRANCE TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY DIAGNOSTIC TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 30. SPAIN TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
TABLE 31. SPAIN TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY DIAGNOSTIC TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 32. ITALY TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
TABLE 33. ITALY TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY DIAGNOSTIC TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 34. REST OF EUROPE TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
TABLE 35. REST OF EUROPE TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY DIAGNOSTIC TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 36. ASIA-PACIFIC TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
TABLE 37. ASIA-PACIFIC TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY DIAGNOSTIC TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 38. ASIA-PACIFIC TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 39. CHINA TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
TABLE 40. CHINA TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY DIAGNOSTIC TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 41. JAPAN TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
TABLE 42. JAPAN TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY DIAGNOSTIC TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 43. INDIA TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
TABLE 44. INDIA TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY DIAGNOSTIC TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 45. SOUTH KOREA TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
TABLE 46. SOUTH KOREA TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY DIAGNOSTIC TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 47. AUSTRALIA TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
TABLE 48. AUSTRALIA TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY DIAGNOSTIC TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 49. REST OF ASIA-PACIFIC TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
TABLE 50. REST OF ASIA-PACIFIC TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY DIAGNOSTIC TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 51. LAMEA TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
TABLE 52. LAMEA TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY DIAGNOSTIC TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 53. LAMEA TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 54. BRAZIL TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
TABLE 55. BRAZIL TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY DIAGNOSTIC TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 56. SAUDI ARABIA TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
TABLE 57. SAUDI ARABIA TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY DIAGNOSTIC TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 58. UAE TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
TABLE 59. UAE TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY DIAGNOSTIC TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 60. SOUTH AFRICA TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
TABLE 61. SOUTH AFRICA TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY DIAGNOSTIC TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 62. REST OF LAMEA TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
TABLE 63. REST OF LAMEA TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY DIAGNOSTIC TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 64. BRAINSCOPE COMPANY INC.: KEY EXECUTIVES
TABLE 65. BRAINSCOPE COMPANY INC.: COMPANY SNAPSHOT
TABLE 66. BRAINSCOPE COMPANY INC.: OPERATING SEGMENTS
TABLE 67. BRAINSCOPE COMPANY INC.: PRODUCT PORTFOLIO
TABLE 68. BRAINSCOPE COMPANY INC.: NET SALES
TABLE 69. BRAINSCOPE COMPANY INC.: KEY STRATERGIES
TABLE 70. NOVASIGNAL CORPORATION: KEY EXECUTIVES
TABLE 71. NOVASIGNAL CORPORATION: COMPANY SNAPSHOT
TABLE 72. NOVASIGNAL CORPORATION: OPERATING SEGMENTS
TABLE 73. NOVASIGNAL CORPORATION: PRODUCT PORTFOLIO
TABLE 74. NOVASIGNAL CORPORATION: NET SALES
TABLE 75. NOVASIGNAL CORPORATION: KEY STRATERGIES
TABLE 76. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: KEY EXECUTIVES
TABLE 77. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT
TABLE 78. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: OPERATING SEGMENTS
TABLE 79. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: PRODUCT PORTFOLIO
TABLE 80. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: NET SALES
TABLE 81. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: KEY STRATERGIES
TABLE 82. NATUS MEDICAL INCORPORATED: KEY EXECUTIVES
TABLE 83. NATUS MEDICAL INCORPORATED: COMPANY SNAPSHOT
TABLE 84. NATUS MEDICAL INCORPORATED: OPERATING SEGMENTS
TABLE 85. NATUS MEDICAL INCORPORATED: PRODUCT PORTFOLIO
TABLE 86. NATUS MEDICAL INCORPORATED: NET SALES
TABLE 87. NATUS MEDICAL INCORPORATED: KEY STRATERGIES
TABLE 88. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
TABLE 89. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 90. BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
TABLE 91. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 92. BOSTON SCIENTIFIC CORPORATION: NET SALES
TABLE 93. BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES
TABLE 94. KONINKLIJKE PHILIPS N.V.: KEY EXECUTIVES
TABLE 95. KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
TABLE 96. KONINKLIJKE PHILIPS N.V.: OPERATING SEGMENTS
TABLE 97. KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
TABLE 98. KONINKLIJKE PHILIPS N.V.: NET SALES
TABLE 99. KONINKLIJKE PHILIPS N.V.: KEY STRATERGIES
TABLE 100. BIODIRECTION, INC.: KEY EXECUTIVES
TABLE 101. BIODIRECTION, INC.: COMPANY SNAPSHOT
TABLE 102. BIODIRECTION, INC.: OPERATING SEGMENTS
TABLE 103. BIODIRECTION, INC.: PRODUCT PORTFOLIO
TABLE 104. BIODIRECTION, INC.: NET SALES
TABLE 105. BIODIRECTION, INC.: KEY STRATERGIES
TABLE 106. NIHON KOHDEN CORP.: KEY EXECUTIVES
TABLE 107. NIHON KOHDEN CORP.: COMPANY SNAPSHOT
TABLE 108. NIHON KOHDEN CORP.: OPERATING SEGMENTS
TABLE 109. NIHON KOHDEN CORP.: PRODUCT PORTFOLIO
TABLE 110. NIHON KOHDEN CORP.: NET SALES
TABLE 111. NIHON KOHDEN CORP.: KEY STRATERGIES
TABLE 112. RAUMEDIC AG: KEY EXECUTIVES
TABLE 113. RAUMEDIC AG: COMPANY SNAPSHOT
TABLE 114. RAUMEDIC AG: OPERATING SEGMENTS
TABLE 115. RAUMEDIC AG: PRODUCT PORTFOLIO
TABLE 116. RAUMEDIC AG: NET SALES
TABLE 117. RAUMEDIC AG: KEY STRATERGIES
TABLE 118. COMPUMEDICS LTD.: KEY EXECUTIVES
TABLE 119. COMPUMEDICS LTD.: COMPANY SNAPSHOT
TABLE 120. COMPUMEDICS LTD.: OPERATING SEGMENTS
TABLE 121. COMPUMEDICS LTD.: PRODUCT PORTFOLIO
TABLE 122. COMPUMEDICS LTD.: NET SALES
TABLE 123. COMPUMEDICS LTD.: KEY STRATERGIES

LIST OF FIGURES

FIGURE 1. SEGMENTATION OF TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET,2021-2031
FIGURE 2. TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET,2021-2031
FIGURE 3. TOP INVESTMENT POCKETS, BY REGION
FIGURE 4. PORTER FIVE-1
FIGURE 5. PORTER FIVE-2
FIGURE 6. PORTER FIVE-3
FIGURE 7. PORTER FIVE-4
FIGURE 8. PORTER FIVE-5
FIGURE 9. TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 10. VALUE CHAIN ANALYSIS
FIGURE 11. KEY REGULATION ANALYSIS
FIGURE 12. PATENT ANALYSIS BY COMPANY
FIGURE 13. PATENT ANALYSIS BY COUNTRY
FIGURE 14. REGULATORY GUIDELINES
FIGURE 15. MARKET SHARE ANALYSIS
FIGURE 16. TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET,BY END-USER,2021(%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF HOSPITAL TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, 2021 AND 2031(%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF DIAGNOSTICS CENTER TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, 2021 AND 2031(%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF OTHERS TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, 2021 AND 2031(%)
FIGURE 20. TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET,BY DIAGNOSTIC TYPE,2021(%)
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF CT-SCAN TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, 2021 AND 2031(%)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF MRI TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, 2021 AND 2031(%)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF INTRACRANIAL PRESSURE MONITORING TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, 2021 AND 2031(%)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF PARTIAL PRESSURE OF OXYGEN IN BRAIN TISSUE (PBRO2) TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, 2021 AND 2031(%)
FIGURE 25. COMPARATIVE SHARE ANALYSIS OF OTHERS TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, 2021 AND 2031(%)
FIGURE 26. TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET BY REGION,2021
FIGURE 27. U.S. TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET,2021-2031($MILLION)
FIGURE 28. CANADA TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET,2021-2031($MILLION)
FIGURE 29. MEXICO TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET,2021-2031($MILLION)
FIGURE 30. GERMANY TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET,2021-2031($MILLION)
FIGURE 31. UK TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET,2021-2031($MILLION)
FIGURE 32. FRANCE TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET,2021-2031($MILLION)
FIGURE 33. SPAIN TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET,2021-2031($MILLION)
FIGURE 34. ITALY TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET,2021-2031($MILLION)
FIGURE 35. REST OF EUROPE TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET,2021-2031($MILLION)
FIGURE 36. CHINA TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET,2021-2031($MILLION)
FIGURE 37. JAPAN TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET,2021-2031($MILLION)
FIGURE 38. INDIA TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET,2021-2031($MILLION)
FIGURE 39. SOUTH KOREA TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET,2021-2031($MILLION)
FIGURE 40. AUSTRALIA TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET,2021-2031($MILLION)
FIGURE 41. REST OF ASIA-PACIFIC TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET,2021-2031($MILLION)
FIGURE 42. BRAZIL TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET,2021-2031($MILLION)
FIGURE 43. SAUDI ARABIA TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET,2021-2031($MILLION)
FIGURE 44. UAE TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET,2021-2031($MILLION)
FIGURE 45. SOUTH AFRICA TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET,2021-2031($MILLION)
FIGURE 46. REST OF LAMEA TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET,2021-2031($MILLION)
FIGURE 47. TOP WINNING STRATEGIES, BY YEAR
FIGURE 48. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 49. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 50. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 51. COMPETITIVE DASHBOARD
FIGURE 52. COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 53. TOP PLAYER POSITIONING, 2021
FIGURE 54. BRAINSCOPE COMPANY INC..: NET SALES ($MILLION)
FIGURE 55. NOVASIGNAL CORPORATION.: NET SALES ($MILLION)
FIGURE 56. INTEGRA LIFESCIENCES HOLDINGS CORPORATION.: NET SALES ($MILLION)
FIGURE 57. NATUS MEDICAL INCORPORATED.: NET SALES ($MILLION)
FIGURE 58. BOSTON SCIENTIFIC CORPORATION.: NET SALES ($MILLION)
FIGURE 59. KONINKLIJKE PHILIPS N.V..: NET SALES ($MILLION)
FIGURE 60. BIODIRECTION, INC..: NET SALES ($MILLION)
FIGURE 61. NIHON KOHDEN CORP..: NET SALES ($MILLION)
FIGURE 62. RAUMEDIC AG.: NET SALES ($MILLION)
FIGURE 63. COMPUMEDICS LTD..: NET SALES ($MILLION)

Product Code: A31382

The global traumatic brain injuries assessment market size was $9,570 million in 2021 and is predicted to expand at a CAGR of 7.0% % by generating a revenue of $18,373.6 million by 2031.

Traumatic brain injuries assessment market growth is a significant public health issue in India. They contribute to the demise, harm, and disabling of young, active members of society. India suffers huge economic losses due to TBIs, yet they are unquantifiable. TBIs will rise in India as it moves toward greater growth and development in terms of motorization and urbanization. The World Health Organization's recent world reports on road traffic injury prevention and violence &health make clear how serious the problem of injuries is getting around the world and how urgently programs for prevention, management, and rehabilitation need to be designed and evaluated. India is one nation that has not prioritized prevention.

TBIs negatively affect executive function and self-control. The ability to control stress- and anxiety-related behavior is known as self-regulation. For someone with a TBI, this can involve difficulty settling down, difficulty waiting their turn, or having overpowering emotions in strange settings. Executive functioning refers to higher-order brain functions that are involved in planning, recalling, setting goals, focusing attention, and obeying directions. TBI sufferers may easily become disoriented or forget things, and they may find it challenging to learn new information, complete paperwork, or use public transportation.

The adoption of the most recent technologies and the launch of new products by market participants are expected to accelerate market expansion during the forecast period. For instance, Bio Direction, Inc.'s NanoDx system is a quick point-of-care (POC) diagnostic that accurately diagnoses concussions/TBIs in under two minutes.

The study, which is being funded by the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR), is still in progress, but preliminary findings indicate that the pandemic has a significant impact on those who have had brain injuries, including social isolation, disruption of daily life, and effects on cognition. The Administration for Community Living-funded Traumatic Brain Damage Technical Assistance and Resource Center (TBI TARC) set out to further study how COVID-19 has affected people with brain injuries. The TBI Advisory and Leadership (TAL) group's five members were questioned by the TBI TARC. The TAL group's goal is to direct TBI TARC's priorities.

The key players profiled in this report include: Integra Lifesciences, BioDirection, Inc., Nihon Kohden Corp., Compumedics Ltd., InfraScan, Inc., Oculogica, Raumedic AG, Zagros Petrochemical Co., Koninklijke Philips N.V, Boston Scientific Corporation, and Elekta.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the traumatic brain injuries assessment market analysis from 2021 to 2031 to identify the prevailing traumatic brain injuries assessment market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the traumatic brain injuries assessment market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global traumatic brain injuries assessment market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By End-user

Hospital
Diagnostics Center
Others

By Diagnostic Type

CT-Scan
MRI
Intracranial Pressure Monitoring
Partial Pressure of Oxygen in Brain Tissue (pBrO2)
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- UAE
- South Africa
- Rest of LAMEA

Key Market Players

brainscope company inc.
NOVASIGNAL CORPORATION
Integra LifeSciences Holdings Corporation
Natus Medical Incorporated
Boston Scientific Corporation
Koninklijke Philips N.V.
BioDirection, Inc.
Nihon Kohden Corp.
RAUMEDIC AG
Compumedics Ltd.

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings
- 3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Market dynamics
- 3.4.1.Drivers
- 3.4.2.Restraints
- 3.4.3.Opportunities
3.5.COVID-19 Impact Analysis on the market
3.6.Value Chain Analysis
3.7.Key Regulation Analysis
3.8.Patent Landscape
3.9.Regulatory Guidelines
3.10.Market Share Analysis

CHAPTER 4: TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY END-USER

4.1 Overview
- 4.1.1 Market size and forecast
4.2. Hospital
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market share analysis by country
4.3. Diagnostics Center
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market share analysis by country
4.4. Others
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market share analysis by country

CHAPTER 5: TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY DIAGNOSTIC TYPE

5.1 Overview
- 5.1.1 Market size and forecast
5.2. CT-Scan
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market share analysis by country
5.3. MRI
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market share analysis by country
5.4. Intracranial Pressure Monitoring
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market share analysis by country
5.5. Partial Pressure of Oxygen in Brain Tissue (pBrO2)
- 5.5.1 Key market trends, growth factors and opportunities
- 5.5.2 Market size and forecast, by region
- 5.5.3 Market share analysis by country
5.6. Others
- 5.6.1 Key market trends, growth factors and opportunities
- 5.6.2 Market size and forecast, by region
- 5.6.3 Market share analysis by country

CHAPTER 6: TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY REGION

6.1 Overview
- 6.1.1 Market size and forecast
6.2 North America
- 6.2.1 Key trends and opportunities
- 6.2.2 North America Market size and forecast, by End-user
- 6.2.3 North America Market size and forecast, by Diagnostic Type
- 6.2.4 North America Market size and forecast, by country
  - 6.2.4.1 U.S.
  - 6.2.4.1.1 Key market trends, growth factors and opportunities
  - 6.2.4.1.2 Market size and forecast, by End-user
  - 6.2.4.1.3 Market size and forecast, by Diagnostic Type
  - 6.2.4.2 Canada
  - 6.2.4.2.1 Key market trends, growth factors and opportunities
  - 6.2.4.2.2 Market size and forecast, by End-user
  - 6.2.4.2.3 Market size and forecast, by Diagnostic Type
  - 6.2.4.3 Mexico
  - 6.2.4.3.1 Key market trends, growth factors and opportunities
  - 6.2.4.3.2 Market size and forecast, by End-user
  - 6.2.4.3.3 Market size and forecast, by Diagnostic Type
6.3 Europe
- 6.3.1 Key trends and opportunities
- 6.3.2 Europe Market size and forecast, by End-user
- 6.3.3 Europe Market size and forecast, by Diagnostic Type
- 6.3.4 Europe Market size and forecast, by country
  - 6.3.4.1 Germany
  - 6.3.4.1.1 Key market trends, growth factors and opportunities
  - 6.3.4.1.2 Market size and forecast, by End-user
  - 6.3.4.1.3 Market size and forecast, by Diagnostic Type
  - 6.3.4.2 UK
  - 6.3.4.2.1 Key market trends, growth factors and opportunities
  - 6.3.4.2.2 Market size and forecast, by End-user
  - 6.3.4.2.3 Market size and forecast, by Diagnostic Type
  - 6.3.4.3 France
  - 6.3.4.3.1 Key market trends, growth factors and opportunities
  - 6.3.4.3.2 Market size and forecast, by End-user
  - 6.3.4.3.3 Market size and forecast, by Diagnostic Type
  - 6.3.4.4 Spain
  - 6.3.4.4.1 Key market trends, growth factors and opportunities
  - 6.3.4.4.2 Market size and forecast, by End-user
  - 6.3.4.4.3 Market size and forecast, by Diagnostic Type
  - 6.3.4.5 Italy
  - 6.3.4.5.1 Key market trends, growth factors and opportunities
  - 6.3.4.5.2 Market size and forecast, by End-user
  - 6.3.4.5.3 Market size and forecast, by Diagnostic Type
  - 6.3.4.6 Rest of Europe
  - 6.3.4.6.1 Key market trends, growth factors and opportunities
  - 6.3.4.6.2 Market size and forecast, by End-user
  - 6.3.4.6.3 Market size and forecast, by Diagnostic Type
6.4 Asia-Pacific
- 6.4.1 Key trends and opportunities
- 6.4.2 Asia-Pacific Market size and forecast, by End-user
- 6.4.3 Asia-Pacific Market size and forecast, by Diagnostic Type
- 6.4.4 Asia-Pacific Market size and forecast, by country
  - 6.4.4.1 China
  - 6.4.4.1.1 Key market trends, growth factors and opportunities
  - 6.4.4.1.2 Market size and forecast, by End-user
  - 6.4.4.1.3 Market size and forecast, by Diagnostic Type
  - 6.4.4.2 Japan
  - 6.4.4.2.1 Key market trends, growth factors and opportunities
  - 6.4.4.2.2 Market size and forecast, by End-user
  - 6.4.4.2.3 Market size and forecast, by Diagnostic Type
  - 6.4.4.3 India
  - 6.4.4.3.1 Key market trends, growth factors and opportunities
  - 6.4.4.3.2 Market size and forecast, by End-user
  - 6.4.4.3.3 Market size and forecast, by Diagnostic Type
  - 6.4.4.4 South Korea
  - 6.4.4.4.1 Key market trends, growth factors and opportunities
  - 6.4.4.4.2 Market size and forecast, by End-user
  - 6.4.4.4.3 Market size and forecast, by Diagnostic Type
  - 6.4.4.5 Australia
  - 6.4.4.5.1 Key market trends, growth factors and opportunities
  - 6.4.4.5.2 Market size and forecast, by End-user
  - 6.4.4.5.3 Market size and forecast, by Diagnostic Type
  - 6.4.4.6 Rest of Asia-Pacific
  - 6.4.4.6.1 Key market trends, growth factors and opportunities
  - 6.4.4.6.2 Market size and forecast, by End-user
  - 6.4.4.6.3 Market size and forecast, by Diagnostic Type
6.5 LAMEA
- 6.5.1 Key trends and opportunities
- 6.5.2 LAMEA Market size and forecast, by End-user
- 6.5.3 LAMEA Market size and forecast, by Diagnostic Type
- 6.5.4 LAMEA Market size and forecast, by country
  - 6.5.4.1 Brazil
  - 6.5.4.1.1 Key market trends, growth factors and opportunities
  - 6.5.4.1.2 Market size and forecast, by End-user
  - 6.5.4.1.3 Market size and forecast, by Diagnostic Type
  - 6.5.4.2 Saudi Arabia
  - 6.5.4.2.1 Key market trends, growth factors and opportunities
  - 6.5.4.2.2 Market size and forecast, by End-user
  - 6.5.4.2.3 Market size and forecast, by Diagnostic Type
  - 6.5.4.3 UAE
  - 6.5.4.3.1 Key market trends, growth factors and opportunities
  - 6.5.4.3.2 Market size and forecast, by End-user
  - 6.5.4.3.3 Market size and forecast, by Diagnostic Type
  - 6.5.4.4 South Africa
  - 6.5.4.4.1 Key market trends, growth factors and opportunities
  - 6.5.4.4.2 Market size and forecast, by End-user
  - 6.5.4.4.3 Market size and forecast, by Diagnostic Type
  - 6.5.4.5 Rest of LAMEA
  - 6.5.4.5.1 Key market trends, growth factors and opportunities
  - 6.5.4.5.2 Market size and forecast, by End-user
  - 6.5.4.5.3 Market size and forecast, by Diagnostic Type

CHAPTER 7: COMPETITIVE LANDSCAPE

7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top player positioning, 2021

CHAPTER 8: COMPANY PROFILES

8.1 brainscope company inc.
- 8.1.1 Company overview
- 8.1.2 Key Executives
- 8.1.3 Company snapshot
- 8.1.4 Operating business segments
- 8.1.5 Product portfolio
- 8.1.6 Business performance
- 8.1.7 Key strategic moves and developments
8.2 NOVASIGNAL CORPORATION
- 8.2.1 Company overview
- 8.2.2 Key Executives
- 8.2.3 Company snapshot
- 8.2.4 Operating business segments
- 8.2.5 Product portfolio
- 8.2.6 Business performance
- 8.2.7 Key strategic moves and developments
8.3 Integra LifeSciences Holdings Corporation
- 8.3.1 Company overview
- 8.3.2 Key Executives
- 8.3.3 Company snapshot
- 8.3.4 Operating business segments
- 8.3.5 Product portfolio
- 8.3.6 Business performance
- 8.3.7 Key strategic moves and developments
8.4 Natus Medical Incorporated
- 8.4.1 Company overview
- 8.4.2 Key Executives
- 8.4.3 Company snapshot
- 8.4.4 Operating business segments
- 8.4.5 Product portfolio
- 8.4.6 Business performance
- 8.4.7 Key strategic moves and developments
8.5 Boston Scientific Corporation
- 8.5.1 Company overview
- 8.5.2 Key Executives
- 8.5.3 Company snapshot
- 8.5.4 Operating business segments
- 8.5.5 Product portfolio
- 8.5.6 Business performance
- 8.5.7 Key strategic moves and developments
8.6 Koninklijke Philips N.V.
- 8.6.1 Company overview
- 8.6.2 Key Executives
- 8.6.3 Company snapshot
- 8.6.4 Operating business segments
- 8.6.5 Product portfolio
- 8.6.6 Business performance
- 8.6.7 Key strategic moves and developments
8.7 BioDirection, Inc.
- 8.7.1 Company overview
- 8.7.2 Key Executives
- 8.7.3 Company snapshot
- 8.7.4 Operating business segments
- 8.7.5 Product portfolio
- 8.7.6 Business performance
- 8.7.7 Key strategic moves and developments
8.8 Nihon Kohden Corp.
- 8.8.1 Company overview
- 8.8.2 Key Executives
- 8.8.3 Company snapshot
- 8.8.4 Operating business segments
- 8.8.5 Product portfolio
- 8.8.6 Business performance
- 8.8.7 Key strategic moves and developments
8.9 RAUMEDIC AG
- 8.9.1 Company overview
- 8.9.2 Key Executives
- 8.9.3 Company snapshot
- 8.9.4 Operating business segments
- 8.9.5 Product portfolio
- 8.9.6 Business performance
- 8.9.7 Key strategic moves and developments
8.10 Compumedics Ltd.
- 8.10.1 Company overview
- 8.10.2 Key Executives
- 8.10.3 Company snapshot
- 8.10.4 Operating business segments
- 8.10.5 Product portfolio
- 8.10.6 Business performance
- 8.10.7 Key strategic moves and developments

外傷性脳損傷（TBI）評価市場：エンドユーザー別、診断タイプ別（CT-スキャン、MRI、頭蓋内圧モニタリング、脳組織酸素分圧、その他）：世界の機会分析と産業予測、2021年～2031年

Traumatic brain injuries assessment Market By End-user, By Diagnostic Type (CT-Scan, MRI, Intracranial Pressure Monitoring, Partial Pressure of Oxygen in Brain Tissue, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場概要

第4章外傷性脳損傷（TBI）評価市場：エンドユーザー別

第5章外傷性脳損傷（TBI）評価市場：診断タイプ別

第6章外傷性脳損傷（TBI）評価市場：地域別

第7章競合情勢

第8章企業プロファイル

LIST OF TABLES

LIST OF FIGURES

Key Benefits For Stakeholders

Key Market Segments

By End-user

By Diagnostic Type

By Region

Key Market Players

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

CHAPTER 2:EXECUTIVE SUMMARY

CHAPTER 3:MARKET OVERVIEW

CHAPTER 4: TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY END-USER

CHAPTER 5: TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY DIAGNOSTIC TYPE

CHAPTER 6: TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY REGION

CHAPTER 7: COMPETITIVE LANDSCAPE

CHAPTER 8: COMPANY PROFILES

外傷性脳損傷（TBI）評価市場：エンドユーザー別、診断タイプ別（CT-スキャン、MRI、頭蓋内圧モニタリング、脳組織酸素分圧、その他）：世界の機会分析と産業予測、2021年～2031年

Traumatic brain injuries assessment Market By End-user, By Diagnostic Type (CT-Scan, MRI, Intracranial Pressure Monitoring, Partial Pressure of Oxygen in Brain Tissue, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

第4章 外傷性脳損傷（TBI）評価市場：エンドユーザー別

第5章 外傷性脳損傷（TBI）評価市場：診断タイプ別

第6章 外傷性脳損傷（TBI）評価市場：地域別

第7章 競合情勢

第8章 企業プロファイル

LIST OF TABLES

LIST OF FIGURES

Key Benefits For Stakeholders

Key Market Segments

By End-user

By Diagnostic Type

By Region

Key Market Players

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

CHAPTER 2:EXECUTIVE SUMMARY

CHAPTER 3:MARKET OVERVIEW

CHAPTER 4: TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY END-USER

CHAPTER 5: TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY DIAGNOSTIC TYPE

CHAPTER 6: TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY REGION

CHAPTER 7: COMPETITIVE LANDSCAPE

CHAPTER 8: COMPANY PROFILES

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場概要

第4章外傷性脳損傷（TBI）評価市場：エンドユーザー別

第5章外傷性脳損傷（TBI）評価市場：診断タイプ別

第6章外傷性脳損傷（TBI）評価市場：地域別

第7章競合情勢

第8章企業プロファイル